Back
Nxera Pharma Stock Price Chart
Sponsored
SOLTF
Sponsored
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free
Sell
16
SOLTF
Nxera Pharma
Last Price:
$6.52
Seasonality Move:
11.8%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the power of "two-minute trades"
Learn how today!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
Nxera Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.34 | Buy |
20-day SMA: | 6.48 | Buy |
50-day SMA: | 7.23 | Sell |
200-day SMA: | 8.92 | Sell |
8-day EMA: | 6.42 | Buy |
20-day EMA: | 6.58 | Sell |
50-day EMA: | 7.15 | Sell |
200-day EMA: | 8.7 | Sell |
Nxera Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 37.98 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.2 - 7.14) | Sell |
Bollinger Bands (100): | (6.94 - 9.08) | Sell |
Nxera Pharma Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Nxera Pharma Stock
Is Nxera Pharma Stock a Buy?
-
Nxera Pharma share price is 6.52 while SOLTF 8-day simple moving average is 6.34, which is a Buy signal.
-
The stock price of SOLTF is 6.52 while Nxera Pharma 20-day SMA is 6.48, which makes it a Buy.
-
Nxera Pharma 50-day simple moving average is 7.23 while SOLTF share price is 6.52, making it a Sell technically.
-
SOLTF stock price is 6.52 and Nxera Pharma 200-day simple moving average is 8.92, creating a Sell signal.
SOLTF Technical Analysis vs Fundamental Analysis
Sell
16
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy or a Sell?
-
Nxera Pharma stock is rated a SellThe current Nxera Pharma [SOLTF] share price is $6.52. The Score for SOLTF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Nxera Pharma Stock Info
Market Cap:
586.2M
Price in USD:
6.52
Share Volume:
0
Nxera Pharma 52-Week Range
52-Week High:
13.43
52-Week Low:
6.16
Sell
16
Nxera Pharma (SOLTF)
is a Sell
Nxera Pharma Share Price Forecast
-
What is the Nxera Pharma stock price today?The Nxera Pharma stock price is 6.52 USD today.
-
Will SOLTF stock go up or go down?Nxera Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Nxera Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nxera Pharma is overvalued.
Is Nxera Pharma Stock a Buy?
-
Nxera Pharma share price is 6.52 while SOLTF 8-day exponential moving average is 6.42, which is a Buy signal.
-
The stock price of SOLTF is 6.52 while Nxera Pharma 20-day EMA is 6.58, which makes it a Sell.
-
Nxera Pharma 50-day exponential moving average is 7.15 while SOLTF share price is 6.52, making it a Sell technically.
-
SOLTF stock price is 6.52 and Nxera Pharma 200-day simple moving average is 8.70, creating a Sell signal.
Technical Analysis of Nxera Pharma
Should I short Nxera Pharma stock?
-
SOLTF Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Nxera Pharma is a Sell
-
Nxera Pharma Relative Strength Index (RSI) is 37.98, which suggest Nxera Pharma is oversold
-
The Bollinger Bands (25) for Nxera Pharma is (6.2 - 7.14), which suggest Nxera Pharma is a Sell
-
The Bollinger Bands (100) for Nxera Pharma is (6.94 - 9.08), which suggest Nxera Pharma is a Sell
* Nxera Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.